North Dakota § 25-17-01 Newborn screening education programs and tests

North Dakota Statutes

§ 25-17-01 — Newborn screening education programs and tests

North Dakota § 25-17-01

Title 25Mental and Physical Illness or Disability

Ch. 25-17Testing and Treatment of Newborns

This text of North Dakota § 25-17-01 (Newborn screening education programs and tests) is published on Counsel Stack Legal Research, covering North Dakota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

N.D. Cent. Code § 25-17-01 (2026).

Text

The department shall:

1.Develop and implement a metabolic disease and genetic disease educational program among licensed clinicians, hospital staffs, public health nurses, and the citizens of this state. This educational program must include information about the nature of the diseases and about screening for the early detection of these diseases so that proper measures may be taken to reduce mortality, morbidity, and associated disabilities.

2.Provide, on a statewide basis, a newborn screening program.

3.Coordinate with or refer individuals to public and private health care service providers for long-term followup services for metabolic diseases and genetic diseases.

4.Select a screening laboratory.

5.Store, maintain, and dispose of blood spots used for screening.

Free access — add to your briefcase to read the full text and ask questions with AI

The department shall:
1. Develop and implement a metabolic disease and genetic disease educational program
among licensed clinicians, hospital staffs, public health nurses, and the citizens of this
state. This educational program must include information about the nature of the
diseases and about screening for the early detection of these diseases so that proper
measures may be taken to reduce mortality, morbidity, and associated disabilities.
2. Provide, on a statewide basis, a newborn screening program.
3. Coordinate with or refer individuals to public and private health care service providers
for long-term followup services for metabolic diseases and genetic diseases.
4. Select a screening laboratory.
5. Store, maintain, and dispose of blood spots used for screening.